REPORTS

Let’s Pullulate and Expand Your Business

Conjugate Vaccines Market - Global Professional Analysis and Forecast to 2026

Nov 04, 2019  |  191 PAGES  |  REPORT CODE: CMM228211
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Conjugate Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.0% during the forecast period.

This report presents the market size and development trends by detailing the Conjugate Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Conjugate Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Conjugate Vaccines industry and will help you to build a panoramic view of the industrial development.

Conjugate Vaccines Market, By Type:

  • Pneumococcal

  • Influenza

  • HPV

  • Hepatitis

  • Rotavirus

  • DTP

  • Polio

  • MMR

Conjugate Vaccines Market, By Application:

  • Pediatric

  • Adult

Some of the leading players are as follows:

  • Astellas Pharma Inc

  • MedImmune, LLC

  • CSL Limited

  • Sanofi Pasteur

  • Pfizer

  • GlaxoSmithKline

  • Serum Institute

  • Merck & Co

  • India Pvt. Ltd. (India)

  • Johnson & Johnson

  • Emergent BioSolutions, Inc

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Conjugate Vaccines Market: Technology Type Analysis

  • 4.1 Conjugate Vaccines Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Conjugate Vaccines Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Pneumococcal

    • 4.3.2 Influenza

    • 4.3.3 HPV

    • 4.3.4 Hepatitis

    • 4.3.5 Rotavirus

    • 4.3.6 DTP

    • 4.3.7 Polio

    • 4.3.8 MMR

5 Conjugate Vaccines Market: Product Analysis

  • 5.1 Conjugate Vaccines Product Market Share Analysis, 2018 & 2026

  • 5.2 Conjugate Vaccines Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Conjugate Vaccines Market: Application Analysis

  • 6.1 Conjugate Vaccines Application Market Share Analysis, 2018 & 2026

  • 6.2 Conjugate Vaccines Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Pediatric

    • 6.3.2 Adult

7 Conjugate Vaccines Market: Regional Analysis

  • 7.1 Conjugate Vaccines Regional Market Share Analysis, 2018 & 2026

  • 7.2 Conjugate Vaccines Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Astellas Pharma Inc

    • 9.1.1 Astellas Pharma Inc Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 MedImmune, LLC

    • 9.2.1 MedImmune, LLC Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 CSL Limited

    • 9.3.1 CSL Limited Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Sanofi Pasteur

    • 9.4.1 Sanofi Pasteur Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Pfizer

    • 9.5.1 Pfizer Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 GlaxoSmithKline

    • 9.6.1 GlaxoSmithKline Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Serum Institute

    • 9.7.1 Serum Institute Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Merck & Co

    • 9.8.1 Merck & Co Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 India Pvt. Ltd. (India)

    • 9.9.1 India Pvt. Ltd. (India) Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Johnson & Johnson

    • 9.10.1 Johnson & Johnson Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Emergent BioSolutions, Inc

    • 9.11.1 Emergent BioSolutions, Inc Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 110 Figures and 142 Tables)

  • Figure Pneumococcal Conjugate Vaccines market, 2015 - 2026 (USD Million)

  • Figure Influenza Conjugate Vaccines market, 2015 - 2026 (USD Million)

  • Figure HPV Conjugate Vaccines market, 2015 - 2026 (USD Million)

  • Figure Hepatitis Conjugate Vaccines market, 2015 - 2026 (USD Million)

  • Figure Rotavirus Conjugate Vaccines market, 2015 - 2026 (USD Million)

  • Figure DTP Conjugate Vaccines market, 2015 - 2026 (USD Million)

  • Figure Polio Conjugate Vaccines market, 2015 - 2026 (USD Million)

  • Figure MMR Conjugate Vaccines market, 2015 - 2026 (USD Million)

  • Figure Pediatric market, 2015 - 2026 (USD Million)

  • Figure Adult market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Conjugate Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table North America Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table North America Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table North America Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Canada Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Canada Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Europe Conjugate Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Europe Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Europe Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Europe Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Germany Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Germany Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table France Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table France Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Italy Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Italy Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Spain Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Spain Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Conjugate Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table China Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table China Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Japan Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Japan Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table India Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table India Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Conjugate Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table MEA Conjugate Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table MEA Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table MEA Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table MEA Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Conjugate Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Conjugate Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Conjugate Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Astellas Pharma Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MedImmune, LLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CSL Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Serum Institute Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck & Co Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table India Pvt. Ltd. (India) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Emergent BioSolutions, Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top